Optogenetics Market 2025-2029: Unveiling Growth Developments with the Latest Updates

 This report provides practical insights for business leaders looking to understand market growth, size, and key trends in the optogenetics industry.

 

 Optogenetics Market Valuation Forecast: What Will The Market Be Worth By 2025?
 The optogenetics market size has grown rapidly in recent years. It will grow from $35.91 billion in 2024 to $40.9 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to rise in neurological disorder, increased funding in life sciences, drug discovery and development, mapping neural circuits, optogenetics in drug screening, neurophotonics advances.
 
 The optogenetics market size is expected to see rapid growth in the next few years. It will grow to $71.21 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to therapeutic applications, clinical trials and translation, expansion into non-neuronal cells, optogenetics in brain-machine interfaces, development of novel light-sensitive proteins. Major trends in the forecast period include advancements in optogenetic tools and technologies, collaborations with pharmaceutical companies, optogenetics in drug discovery and development, expansion into non-neural cell types, integration with other imaging technologies.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp
 
 What Are The Key Factors Driving Growth In The Optogenetics Market?
 The rising cases of Parkinson’s disease and epilepsy across are expected to propel the growth of the optogenetics market going forward. Parkinson’s disease (PD) is defined as a degenerative condition of the brain that causes motor symptoms including slow movement tremors, rigidity, and imbalance in addition to other problems such as cognitive decline, mental health issues, sleep issues, pain, and sensory disturbances. Epilepsy is a brain condition that results in seizures. In optogenetic therapy, proteins that respond to specific wavelengths of light are used to treat Parkinson’s disease. These proteins can be produced using gene therapy techniques to either activate or inactivate when exposed to specific types of light, ultimately leading to the normalization of brain function in Parkinson’s disease (PD). For instance, In December 2022, according to The Parkinson’s Foundation, a US-based organization dedicated to improving the lives of individuals affected by Parkinson’s disease, there was a sharp rise in annual Parkinson’s disease diagnoses to nearly 90,000, up from the previous estimate of 60,000. Moreover, the number of people living with PD in the U.S. is expected to increase to 1.2 million by 2030 from 930,000 in 2020. Therefore, a rise in cases of Parkinson’s disease & epilepsy across the world is driving the growth of the optogenetics market forward.
 
 Emerging And High-Growth Segments In The Global Optogenetics Market
 The optogenetics market covered in this report is segmented — 
 
 1) By Product: Lasers, Actuators, Sensors
 2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications
 3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users
 
 Subsegments:
 1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers 
 2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs 
 3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators
 
 Optogenetics Market Future Trends
 The development of innovative systems is the key trend gaining popularity in the optogenetics market. Major companies operating in the optogenetics market are developing innovative optogenetics tools and systems with cutting-edge technologies to sustain their position in the market. For instance, in June 2022, Bruker Corporation, a US-based optogenetics tool manufacturer company launched NeuraLight 3D Ultra, an enhanced 3D holographic stimulation for optogenetics module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra offers cutting-edge 3D holographic photostimulation tailored for in-depth functional research on neural networks and brain computation.
 
 Key Optogenetics Company Insights:
 Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems 
 
 View the full optogenetics market report here:
 https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report
 
 How Does Optogenetics Market Growth Vary Across Major Regions?
 North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company